Prostate Health: PSA Screening and What It Means

Prostate health is a common concern for men as they age. Prostate cancer is the second most common cancer among men, with approximately one in seven men receiving a diagnosis during their lifetime. By age 85, roughly 90% of men will have signs of benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate, and about half of those with BPH will develop symptoms requiring treatment. The PSA (prostate-specific antigen) test has been the standard prostate cancer screening tool for three decades.

Many men experience anxiety about prostate health as they age, particularly regarding PSA testing and the implications of elevated results. While BPH is not cancer and does not increase cancer risk, both conditions can cause symptoms that interfere with daily life and may require monitoring. Understanding screening guidelines, what results indicate, and when testing is appropriate helps men make informed decisions in partnership with their healthcare providers.

Prostate problems are largely driven by normal aging processes. The prostate gland undergoes a second growth phase beginning around age 25 that continues for much of adult life, making BPH the most common prostate condition in men over 50.

Risk factors for prostate problems include family history (male relatives of men with significantly enlarged prostates are roughly four times more likely to require surgical treatment for BPH), age, ethnicity, and overall health status. All of these factors influence PSA levels and prostate cancer risk assessment. Other contributors to prostate health issues include certain medications, infections, and underlying conditions such as diabetes or cardiovascular disease.

PSA screening decisions should involve shared decision-making between the individual and the healthcare provider. Current guidelines recommend offering prostate cancer screening beginning at age 40 to 45 for individuals at increased risk based on Black race, certain genetic mutations, or strong family history. Regular screening every two to four years is suggested for men aged 50 to 69. For men aged 55 to 69, the potential benefits of screening are considered small but real for some individuals.

Men experiencing urinary symptoms such as frequent nighttime urination, difficulty initiating urination, or changes in urinary flow should discuss testing with a healthcare provider, as these symptoms can indicate prostate conditions that warrant evaluation. The decision to screen should account for individual risk factors, overall health and life expectancy, and personal preferences regarding the potential benefits and limitations of PSA testing.

PSA results are interpreted based on age and individual risk profile. For men in their 40s and 50s, PSA above 2.5 ng/mL is considered above the typical median of 0.6 to 0.7 ng/mL. For men in their 60s, PSA above 4.0 ng/mL is generally considered elevated. However, elevated PSA can result from prostate cancer, BPH, or prostate inflammation. Studies show that up to 86% of individuals with BPH may have elevated PSA levels.

An elevated PSA does not automatically indicate cancer, and a normal PSA does not guarantee the absence of prostate problems. When a newly elevated PSA is found, repeating the test before proceeding to secondary evaluation (biomarkers, imaging, or biopsy) is recommended. The rate of PSA change over time, family history, physical examination findings, and other clinical factors all contribute to determining whether further evaluation is warranted. Results should be discussed with a healthcare provider who can interpret them within the full clinical context.

While there is no guaranteed method of preventing prostate problems, certain lifestyle factors may support prostate health. Regular physical activity and maintaining a healthy weight are beneficial, as inactivity can contribute to muscle loss, weight gain, and declining testosterone levels in a self-reinforcing cycle. Some research suggests that limiting red meat and dairy consumption may help reduce BPH risk, as the prostate metabolizes cholesterol effectively and factors that raise cholesterol may promote prostate growth.

Being aware that certain medications can affect urinary symptoms or PSA levels is important. Regular medical checkups become increasingly valuable with age, allowing for early detection and appropriate management of prostate conditions. Managing fluid intake timing, particularly reducing evening consumption, can help minimize nighttime urinary symptoms associated with BPH.